Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kyu-Pyo Kim

Showing results (141-150 of 217) with videos related to

Pageof 22
Sort By:
American Journal of Clinical Oncology|November 1, 2012
A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study GroupYong Sang Hong, Sung Sook Lee, Kyu-pyo Kim, et al.
Cancer Science|January 10, 2013
Second-line cetuximab/irinotecan versus oxaliplatin/fluoropyrimidines for metastatic colorectal cancer with wild-type KRASYong Sang Hong, Hwa Jung Kim, Seong Joon Park, et al.
Gastrointestinal Endoscopy|April 24, 2003
Ectopic opening of the common bile duct in the duodenal bulb: clinical implicationsSang Soo Lee, Myung-Hwan Kim, Sung-Koo Lee, et al.
Nano Letters|November 8, 2019
Multifunctional Nanorobot System for Active Therapeutic Delivery and Synergistic Chemo-photothermal TherapyZhen Jin, Kim Tien Nguyen, Gwangjun Go, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2019
3'-Deoxy-3'-<sup>18</sup>F-Fluorothymidine and <sup>18</sup>F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapiesJeong Eun Kim, Sun Young Chae, Jwa Hoon Kim, et al.
The Oncologist|February 25, 2026
Atezolizumab and Motixafortide, Cobimetinib or Simlukafusp Alfa in Pretreated Advanced Pancreatic Cancer: Phase I/IIb MORPHEUS-PDAC Umbrella StudyGulam A Manji, Vincent Chung, Do-Youn Oh, et al.
Annals of Surgical Oncology|May 7, 2026
Modified FOLFIRINOX with or Without Stereotactic Body Radiation in Locally Advanced Unresectable Pancreatic Cancer (SABER): A Randomized Open-Label Phase 2 TrialChanghoon Yoo, Hyehyun Jeong, Inkeun Park, et al.
American Journal of Clinical Oncology|June 21, 2016
Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable MetastasesHyungwoo Cho, Jeong Eun Kim, Kyu-Pyo Kim, et al.
Endoscopy|June 13, 2015
Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheterJun-Ho Choi, Dongwook Oh, Jae Hoon Lee, et al.
Liver Cancer|March 1, 2019
Characterization of Hepatocellular Carcinoma Patients with <i>FGF19</i> Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort StudyHyo Jeong Kang, Farhan Haq, Chang Ohk Sung, et al.
Pageof 22

Showing results (141-150 of 217) with videos related to

Sort By:
Pageof 22
American Journal of Clinical Oncology|November 1, 2012
A phase II study of bevacizumab, oxaliplatin, and capecitabine in patients with previously untreated metastatic colorectal cancer: a prospective, multicenter trial of the Korean Cancer Study GroupYong Sang Hong, Sung Sook Lee, Kyu-pyo Kim, et al.
Cancer Science|January 10, 2013
Second-line cetuximab/irinotecan versus oxaliplatin/fluoropyrimidines for metastatic colorectal cancer with wild-type KRASYong Sang Hong, Hwa Jung Kim, Seong Joon Park, et al.
Gastrointestinal Endoscopy|April 24, 2003
Ectopic opening of the common bile duct in the duodenal bulb: clinical implicationsSang Soo Lee, Myung-Hwan Kim, Sung-Koo Lee, et al.
Nano Letters|November 8, 2019
Multifunctional Nanorobot System for Active Therapeutic Delivery and Synergistic Chemo-photothermal TherapyZhen Jin, Kim Tien Nguyen, Gwangjun Go, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 2, 2019
3'-Deoxy-3'-<sup>18</sup>F-Fluorothymidine and <sup>18</sup>F-Fluorodeoxyglucose positron emission tomography for the early prediction of response to Regorafenib in patients with metastatic colorectal cancer refractory to all standard therapiesJeong Eun Kim, Sun Young Chae, Jwa Hoon Kim, et al.
The Oncologist|February 25, 2026
Atezolizumab and Motixafortide, Cobimetinib or Simlukafusp Alfa in Pretreated Advanced Pancreatic Cancer: Phase I/IIb MORPHEUS-PDAC Umbrella StudyGulam A Manji, Vincent Chung, Do-Youn Oh, et al.
Annals of Surgical Oncology|May 7, 2026
Modified FOLFIRINOX with or Without Stereotactic Body Radiation in Locally Advanced Unresectable Pancreatic Cancer (SABER): A Randomized Open-Label Phase 2 TrialChanghoon Yoo, Hyehyun Jeong, Inkeun Park, et al.
American Journal of Clinical Oncology|June 21, 2016
Phase II Study of Preoperative Capecitabine and Oxaliplatin-based Intensified Chemoradiotherapy With or Without Induction Chemotherapy in Patients With Locally Advanced Rectal Cancer and Synchronous Liver-limited Resectable MetastasesHyungwoo Cho, Jeong Eun Kim, Kyu-Pyo Kim, et al.
Endoscopy|June 13, 2015
Initial human experience of endoscopic ultrasound-guided photodynamic therapy with a novel photosensitizer and a flexible laser-light catheterJun-Ho Choi, Dongwook Oh, Jae Hoon Lee, et al.
Liver Cancer|March 1, 2019
Characterization of Hepatocellular Carcinoma Patients with <i>FGF19</i> Amplification Assessed by Fluorescence in situ Hybridization: A Large Cohort StudyHyo Jeong Kang, Farhan Haq, Chang Ohk Sung, et al.
Pageof 22